These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 8348744)

  • 1. Determination of soluble CD21 as a parameter of B cell activation.
    Huemer HP; Larcher C; Prodinger WM; Petzer AL; Mitterer M; Falser N
    Clin Exp Immunol; 1993 Aug; 93(2):195-9. PubMed ID: 8348744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of Epstein-Barr virus nuclear antigen-2 (EBNA2) induces CD21/CR2 on B and T cell lines and shedding of soluble CD21.
    Larcher C; Kempkes B; Kremmer E; Prodinger WM; Pawlita M; Bornkamm GW; Dierich MP
    Eur J Immunol; 1995 Jun; 25(6):1713-9. PubMed ID: 7614999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of the CD21 antigen in lymphocyte transformation by Epstein-Barr virus.
    Boyd AW; Fecondo J
    Immunol Cell Biol; 1988 Apr; 66 ( Pt 2)():159-65. PubMed ID: 2846436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human B and T lymphocytes have similar amounts of CD21 mRNA, but differ in surface expression of the CD21 glycoprotein.
    Braun M; Melchers I; Peter HH; Illges H
    Int Immunol; 1998 Aug; 10(8):1197-202. PubMed ID: 9723706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD23/CD21 interaction is required for presentation of soluble protein antigen by lymphoblastoid B cell lines to specific CD4+ T cell clones.
    Grosjean I; Lachaux A; Bella C; Aubry JP; Bonnefoy JY; Kaiserlian D
    Eur J Immunol; 1994 Dec; 24(12):2982-6. PubMed ID: 7805725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of an Epstein-Barr virus receptor on human epithelial cells.
    Birkenbach M; Tong X; Bradbury LE; Tedder TF; Kieff E
    J Exp Med; 1992 Nov; 176(5):1405-14. PubMed ID: 1383386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epstein-Barr virus (EBV) infection in B-cell non-Hodgkin's lymphomas in children: virus latency and its correlation with CD21 and CD23 molecules.
    Kasprzak A; Spachacz R; Wachowiak J; Stefanska K; Zabel M
    Folia Histochem Cytobiol; 2007; 45(3):169-79. PubMed ID: 17951165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T cell activation induced by cross-linking CD3 and CD28 leads to silencing of Epstein-Barr virus/C3d receptor (CR2/CD21) gene and protein expression.
    Masilamani M; von Seydlitz E; Bastmeyer M; Illges H
    Immunobiology; 2002 Dec; 206(5):528-36. PubMed ID: 12607728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. B cell activation leads to shedding of complement receptor type II (CR2/CD21).
    Masilamani M; Kassahn D; Mikkat S; Glocker MO; Illges H
    Eur J Immunol; 2003 Sep; 33(9):2391-7. PubMed ID: 12938215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An Epstein-Barr virus susceptible immature T-cell line, WILL4, established from a patient with T-lymphoblastic lymphoma bearing CD21 and a clonal EBV genome.
    Hosoi H; Imadome KI; Tamura S; Kuriyama K; Murata S; Yamashita Y; Mushino T; Oiwa T; Kobata H; Nishikawa A; Nakakuma H; Hanaoka N; Isobe Y; Ohshima K; Sonoki T
    Leuk Res; 2017 Apr; 55():1-5. PubMed ID: 28110206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical absence of CD21 membrane receptor in nasopharyngeal carcinoma cells infected by Epstein-Barr virus in Spanish patients.
    Burgos JS; Vera-Sempere FJ
    Laryngoscope; 2000 Dec; 110(12):2081-4. PubMed ID: 11129025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complement opsonization is required for presentation of immune complexes by resting peripheral blood B cells.
    Boackle SA; Morris MA; Holers VM; Karp DR
    J Immunol; 1998 Dec; 161(12):6537-43. PubMed ID: 9862679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epstein-Barr virus binding to CD21, the virus receptor, activates resting B cells via an intracellular pathway that is linked to B cell infection.
    Roberts ML; Luxembourg AT; Cooper NR
    J Gen Virol; 1996 Dec; 77 ( Pt 12)():3077-85. PubMed ID: 9000100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD21 augments antigen presentation in immune individuals.
    Boackle SA; Holers VM; Karp DR
    Eur J Immunol; 1997 Jan; 27(1):122-9. PubMed ID: 9022008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased levels of serum soluble complement receptor-II (CR2/CD21) in patients with rheumatoid arthritis.
    Masilamani M; von Kempis J; Illges H
    Rheumatology (Oxford); 2004 Feb; 43(2):186-90. PubMed ID: 12867574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human T lymphotropic virus-type I Tax induction of CD21/Epstein-Barr virus receptor expression on T cells and its significance in leukemogenesis of adult T cell leukemia.
    Ohtsubo H; Arima N; Matsushita K; Hidaka S; Fujiwara H; Arimura K; Kukita T; Fukumori J; Matsumoto T; Eizuru Y; Tanaka H
    Exp Hematol; 1997 Nov; 25(12):1246-52. PubMed ID: 9357968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human lymphocytes shed a soluble form of CD21 (the C3dg/Epstein-Barr virus receptor, CR2) that binds iC3b and CD23.
    Frémeaux-Bacchi V; Bernard I; Maillet F; Mani JC; Fontaine M; Bonnefoy JY; Kazatchkine MD; Fischer E
    Eur J Immunol; 1996 Jul; 26(7):1497-503. PubMed ID: 8766552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stimulation of human IgE production by a subset of anti-CD21 monoclonal antibodies: requirement of a co-signal to modulate epsilon transcripts.
    Henchoz S; Gauchat JF; Aubry JP; Graber P; Pochon S; Bonnefoy JY
    Immunology; 1994 Feb; 81(2):285-90. PubMed ID: 7512529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epstein-Barr virus and CD21 expression in gastrointestinal tumors.
    Kim YS; Paik SR; Kim HK; Yeom BW; Kim I; Lee D
    Pathol Res Pract; 1998; 194(10):705-11. PubMed ID: 9820867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of complement receptor 2 (CD21), membrane IgM and the inhibitory receptor CD32 (FcgammaRIIb) in the lymphoid tissues of neonatal calves.
    Chattha KS; Firth MA; Hodgins DC; Shewen PE
    Vet Immunol Immunopathol; 2010 Sep; 137(1-2):99-108. PubMed ID: 20488561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.